Announcements
The new Eurosurveillance website is almost here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc


Skip Navigation LinksEurosurveillance Archives
Eurosurveillance:
2017        2016        2015        2014        2013        2012        2011        2010        2009        2008        2007        2006       
2005        2004        2003        2002        2001        2000        1999        1998        1997        1996        1995       

Eurosurveillance Editions 2017,  Volume 22:
Sep: 14 | 07 |
Aug: 31 | 24 | 17 | 10 | 03 |
Jul: 27 | 20 | 13 | 06 |
Jun: 29 | 22 | 15 | 08 | 01 |
May: 25 | 18 | 11 | 04 |
Apr: 27 | 20 | 13 | 06 |
Mar: 30 | 23 | 16 | 09 | 02 |
Feb: 23 | 16 | 09 | 02 |
Jan: 26 | 19 | 12 | 05 |

Eurosurveillance Special Editions 2017,  Volume 22:
  Special issue on Immunisation Information Systems - August 2017


In this issue:
With World Hepatitis Day tomorrow, two of this week’s articles investigate the prevalence of hepatitis C in Ireland and factors associated with severe liver disease in France.


Eurosurveillance, Volume 22, Issue 30, 27 July 2017

Table of Contents

Rapid communications

Outbreak of intestinal amoebiasis among men who have sex with men, Barcelona (Spain), October 2016 and January 2017
Abstract
Research Articles

2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project
Abstract
Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014
Abstract
Hepatitis C virus seroprevalence and prevalence of chronic infection in the adult population in Ireland: a study of residual sera, April 2014 to February 2016
Abstract

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.